资讯内容 Content
SSSS Study:Cost-effectiveness of simvastatin in the secondary prevention of coronary artery disease in Canada.
国际循环网版权所有，谢绝任何形式转载，侵犯版权者必予法律追究。
6108 respectively.
CONCLUSION: This model suggests that simvastatin provides a cost-effective approach to the long-term prevention of secondary CAD in Canada.
上一页 [1] [2] [3]